• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质的左型谷胱甘肽加合物在血小板激活后通过前列腺素H2合酶依赖性途径形成。

Levuglandinyl adducts of proteins are formed via a prostaglandin H2 synthase-dependent pathway after platelet activation.

作者信息

Boutaud Olivier, Li Junyu, Zagol Irene, Shipp Elizabeth A, Davies Sean S, Roberts L Jackson, Oates John A

机构信息

Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232-6602, USA.

出版信息

J Biol Chem. 2003 May 9;278(19):16926-8. doi: 10.1074/jbc.M300940200. Epub 2003 Mar 11.

DOI:10.1074/jbc.M300940200
PMID:12637576
Abstract

The product of oxygenation of arachidonic acid by the prostaglandin H synthases (PGHS), prostaglandin H(2) (PGH(2)), undergoes rearrangement to the highly reactive gamma-ketoaldehydes, levuglandin (LG) E(2), and LGD(2). We have demonstrated previously that LGE(2) reacts with the epsilon-amine of lysine to form both the levuglandinyl-lysine Schiff base and the pyrrole-derived levuglandinyl-lysine lactam adducts. We also have reported that these levuglandinyl-lysine adducts are formed on purified PGHSs following the oxygenation of arachidonic acid. We now present evidence that the levuglandinyl-lysine lactam adduct is formed in human platelets upon activation with exogenous arachidonic acid or thrombin. After proteolytic digestion of the platelet proteins, and isolation of the adducted amino acid residues, this adduct was identified by liquid chromatography-tandem mass spectrometry. We also demonstrate that formation of these adducts is inhibited by indomethacin, a PGHS inhibitor, and is enhanced by an inhibitor of thromboxane synthase. These data establish that levuglandinyl-lysine adducts are formed via a PGHS-dependent pathway in whole cells, even in the presence of an enzyme that metabolizes PGH(2). They also demonstrate that a physiological stimulus is sufficient to lead to the lipid modification of proteins through the levuglandin pathway in human platelets.

摘要

花生四烯酸经前列腺素H合成酶(PGHS)氧化的产物前列腺素H2(PGH2)会重排为高反应性的γ-酮醛,即左型前列腺素(LG)E2和LGD2。我们之前已经证明,LGE2与赖氨酸的ε-氨基反应,形成左型前列腺素赖氨酸席夫碱和吡咯衍生的左型前列腺素赖氨酸内酰胺加合物。我们还报道过,这些左型前列腺素赖氨酸加合物是在花生四烯酸氧化后在纯化的PGHS上形成的。我们现在提供证据表明,在用外源性花生四烯酸或凝血酶激活后,人血小板中会形成左型前列腺素赖氨酸内酰胺加合物。在对血小板蛋白进行蛋白水解消化并分离出加合的氨基酸残基后,通过液相色谱-串联质谱法鉴定了这种加合物。我们还证明,这些加合物的形成受到PGHS抑制剂吲哚美辛的抑制,并被血栓素合酶抑制剂增强。这些数据表明,即使存在代谢PGH2的酶,左型前列腺素赖氨酸加合物也是通过全细胞中依赖PGHS的途径形成的。它们还表明,生理刺激足以通过左型前列腺素途径导致人血小板中蛋白质的脂质修饰。

相似文献

1
Levuglandinyl adducts of proteins are formed via a prostaglandin H2 synthase-dependent pathway after platelet activation.蛋白质的左型谷胱甘肽加合物在血小板激活后通过前列腺素H2合酶依赖性途径形成。
J Biol Chem. 2003 May 9;278(19):16926-8. doi: 10.1074/jbc.M300940200. Epub 2003 Mar 11.
2
Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid.源自花生四烯酸氧化的前列腺素H合酶赖氨酰加合物的表征。
Biochemistry. 2001 Jun 12;40(23):6948-55. doi: 10.1021/bi002629k.
3
Characterization of bis(levuglandinyl) urea derivatives as products of the reaction between prostaglandin H2 and arginine.双(列腺素)尿素衍生物作为前列腺素H2与精氨酸反应产物的表征
Biochemistry. 2004 May 11;43(18):5503-10. doi: 10.1021/bi049842r.
4
Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway.通过左型前列腺素途径由前列腺素H2形成的赖氨酰加合物的表征。
Biochemistry. 1999 Jul 20;38(29):9389-96. doi: 10.1021/bi990470+.
5
Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase.由前列腺素H合酶形成的新型花生四烯酸代谢物的鉴定。
Eur J Biochem. 1987 Nov 16;169(1):113-23. doi: 10.1111/j.1432-1033.1987.tb13587.x.
6
Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin.与左型前列腺素反应形成的核苷和DNA共价加合物的表征
Biochemistry. 2009 Nov 17;48(45):10775-81. doi: 10.1021/bi9015132.
7
Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity.蛋白质的前列腺素H2衍生加合物与阿尔茨海默病的严重程度相关。
J Neurochem. 2005 Aug;94(4):1140-5. doi: 10.1111/j.1471-4159.2005.03264.x. Epub 2005 Jun 30.
8
New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.异前列腺素途径的新进展:新型高反应性γ-酮醛(异左旋精氨酸)的鉴定及其蛋白质加合物的表征。
FASEB J. 1999 Jul;13(10):1157-68. doi: 10.1096/fasebj.13.10.1157.
9
Formation of electronically excited states during the oxidation of arachidonic acid by prostaglandin endoperoxide synthase.
Methods Enzymol. 2000;319:67-77. doi: 10.1016/s0076-6879(00)19009-3.
10
Studies on the reduction of endogenously generated prostaglandin G2 by prostaglandin H synthase.前列腺素H合酶对内源性生成的前列腺素G2的还原作用研究。
J Biol Chem. 1991 Jul 5;266(19):12348-55.

引用本文的文献

1
Dicarbonyl Electrophiles Mediate Inflammation-Induced Gastrointestinal Carcinogenesis.二羰基亲电子试剂介导炎症诱导的胃肠道癌变。
Gastroenterology. 2021 Mar;160(4):1256-1268.e9. doi: 10.1053/j.gastro.2020.11.006. Epub 2020 Nov 13.
2
Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr mice.用 2-羟苯乙胺清除活性二羰基化合物可减少高胆固醇血症 LDLR 小鼠的动脉粥样硬化。
Nat Commun. 2020 Aug 14;11(1):4084. doi: 10.1038/s41467-020-17915-w.
3
Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.
异前列烷作为疾病的介质和二羰基清除剂作为药物干预的发展。
Pharmacol Ther. 2020 Jan;205:107418. doi: 10.1016/j.pharmthera.2019.107418. Epub 2019 Oct 16.
4
Isolevuglandins and cardiovascular disease.异前列腺素与心血管疾病
Prostaglandins Other Lipid Mediat. 2018 Nov;139:29-35. doi: 10.1016/j.prostaglandins.2018.10.002. Epub 2018 Oct 5.
5
Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D.全合成证实了氧化列腺素D的分子结构。
J Nat Prod. 2017 Feb 24;80(2):488-498. doi: 10.1021/acs.jnatprod.6b01048. Epub 2017 Feb 14.
6
Modification of platelet proteins by malondialdehyde: prevention by dicarbonyl scavengers.丙二醛对血小板蛋白的修饰:二羰基清除剂的预防作用
J Lipid Res. 2015 Nov;56(11):2196-205. doi: 10.1194/jlr.P063271. Epub 2015 Sep 16.
7
Isolevuglandin adducts in disease.疾病中的异前列烷加合物。
Antioxid Redox Signal. 2015 Jun 20;22(18):1703-18. doi: 10.1089/ars.2014.6154. Epub 2015 Feb 18.
8
Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA.类花生酸以环氧化酶-2 依赖的方式与组蛋白 h4 形成加合物,改变其与 DNA 的相互作用。
Biochemistry. 2014 Apr 22;53(15):2436-41. doi: 10.1021/bi401673b. Epub 2014 Apr 11.
9
On-tissue chemical derivatization of 3-methoxysalicylamine for MALDI-imaging mass spectrometry.组织内 3-甲氧基水杨酰胺的化学衍生化用于 MALDI 成像质谱。
J Mass Spectrom. 2011 Aug;46(8):840-6. doi: 10.1002/jms.1958.
10
Generation and detection of levuglandins and isolevuglandins in vitro and in vivo.在体外和体内生成和检测莱格舒坦和异莱格舒坦。
Molecules. 2011 Jun 24;16(7):5333-48. doi: 10.3390/molecules16075333.